相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system
Shwu-Maan Lee et al.
SCIENTIFIC REPORTS (2020)
Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy et al.
NPJ VACCINES (2020)
Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins
Kavita Singh et al.
COMMUNICATIONS BIOLOGY (2020)
Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230
Puthupparampil Scaria et al.
VACCINE (2020)
Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP
Darya Urusova et al.
NATURE MICROBIOLOGY (2019)
Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
Susheel K. Singh et al.
FRONTIERS IN IMMUNOLOGY (2019)
Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230
Puthupparampil Scaria et al.
NPJ VACCINES (2019)
Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25
Brandon McLeod et al.
NATURE COMMUNICATIONS (2019)
Malaria Vaccines: Recent Advances and New Horizons
Simon J. Draper et al.
CELL HOST & MICROBE (2018)
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope
Tongqing Zhou et al.
IMMUNITY (2018)
Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity
Will J. R. Stone et al.
NATURE COMMUNICATIONS (2018)
Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission
Gaspar E. Canepa et al.
NPJ VACCINES (2018)
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies
Hongying Duan et al.
IMMUNITY (2018)
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults
Jessica A. Chichester et al.
VACCINE (2018)
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
Frank Lennartz et al.
NATURE COMMUNICATIONS (2018)
Structural delineation of potent transmission- blocking epitope I on malaria antigen Pfs48/45
Prasun Kundu et al.
NATURE COMMUNICATIONS (2018)
Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine
Michael Theisen et al.
EXPERT REVIEW OF VACCINES (2017)
The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle
Silvia A. Arredondo et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2017)
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity
Puthupparampil V. Scaria et al.
PLOS ONE (2017)
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
Stephen W. Scally et al.
NATURE COMMUNICATIONS (2017)
Targeting the Conserved Fusion Loop of HAP2 Inhibits the Transmission of Plasmodium berghei and falciparum
Fiona Angrisano et al.
CELL REPORTS (2017)
Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230
Nicholas J. MacDonald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
Shwu-Maan Lee et al.
MALARIA JOURNAL (2016)
Naturally acquired immunity to sexual stage P. falciparum parasites
Will J. R. Stone et al.
PARASITOLOGY (2016)
Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein
Edwin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay
Kazutoyo Miura et al.
VACCINE (2016)
Safety and Immunogenicityof Pfs25-EPA/Alhydrogel® , a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naive Adults
Kawsar R. Talaat et al.
PLOS ONE (2016)
Toward the development of effective transmission-blocking vaccines for malaria
Daria Nikolaeva et al.
EXPERT REVIEW OF VACCINES (2015)
Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates
Sophie Jones et al.
JOURNAL OF INFECTION (2015)
Transmission- blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants
Will Roeffen et al.
MALARIA JOURNAL (2015)
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Hadi M. Yassine et al.
NATURE MEDICINE (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies
Susheel K. Singh et al.
VACCINE (2015)
The Structure of Plasmodium falciparum Blood-Stage 6-Cys Protein Pf41 Reveals an Unexpected Intra-Domain Insertion Required for Pf12 Coordination
Michelle L. Parker et al.
PLOS ONE (2015)
Comparative Assessment of Transmission-Blocking Vaccine Candidates against Plasmodium falciparum
M. C. Kapulu et al.
SCIENTIFIC REPORTS (2015)
Proof of principle for epitope-focused vaccine design
Bruno E. Correia et al.
NATURE (2014)
A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages
Michael Theisen et al.
VACCINE (2014)
Functional Comparison of Plasmodium falciparum Transmission-Blocking Vaccine Candidates by the Standard Membrane-Feeding Assay
Kazutoyo Miura et al.
INFECTION AND IMMUNITY (2013)
Structural and Biochemical Characterization of Plasmodium falciparum 12 (Pf12) Reveals a Unique Interdomain Organization and the Potential for an Antiparallel Arrangement with Pf41
Michelle L. Tonkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice
R. Mark Jones et al.
PLOS ONE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
The Human Malaria Parasite Pfs47 Gene Mediates Evasion of the Mosquito Immune System
Alvaro Molina-Cruz et al.
SCIENCE (2013)
Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
Richard L. Shimp et al.
VACCINE (2013)
Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175
Edwin Chen et al.
PLOS PATHOGENS (2013)
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing
Magnus Manske et al.
NATURE (2012)
Structure of the Plasmodium 6-cysteine s48/45 domain
Silvia A. Arredondo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
N-Terminal Prodomain of Pfs230 Synthesized Using a Cell-Free System Is Sufficient To Induce Complement-Dependent Malaria Transmission-Blocking Activity
Mayumi Tachibana et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Blood-stage malaria vaccines - recent progress and future challenges
A. L. Goodman et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2010)
From the circumsporozoite protein to the RTS, S/AS candidate vaccine
Joe Cohen et al.
HUMAN VACCINES (2010)
The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania
Teun Bousema et al.
PLOS ONE (2010)
The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species
Lediya Cheru et al.
VACCINE (2010)
Three Members of the 6-cys Protein Family of Plasmodium Play a Role in Gamete Fertility
Melissa R. van Dijk et al.
PLOS PATHOGENS (2010)
A Potent Malaria Transmission Blocking Vaccine Based on Codon Harmonized Full Length Pfs48/45 Expressed in Escherichia coli
Debabani Roy Chowdhury et al.
PLOS ONE (2009)
Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro
Andrew M. Blagborough et al.
VACCINE (2009)
Male fertility of malaria parasites is determined by GCS1, a plant-type reproduction factor
Makoto Hirai et al.
CURRENT BIOLOGY (2008)
The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes
Yanjie Liu et al.
GENES & DEVELOPMENT (2008)
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
Yimin Wu et al.
PLOS ONE (2008)
Correctly folded MUM protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice
Nikolay S. Outchkourov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer
Kazutoyo Miura et al.
MALARIA JOURNAL (2007)
Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production
Saliha Eksi et al.
MOLECULAR MICROBIOLOGY (2006)
Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers
CJ Drakeley et al.
PARASITE IMMUNOLOGY (2006)
The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms
AK Saxena et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum
DL Gerloff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase 1 vaccine trial of Pvs25H:: a transmission blocking vaccine for Plasmodium vivax malaria
EM Malkin et al.
VACCINE (2005)
Do malaria ookinete surface proteins P25 and P28 mediate parasite entry into mosquito midgut epithelial cells?
LA Baton et al.
MALARIA JOURNAL (2005)
Pfs230: from malaria transmission-blocking vaccine candidate toward function
KC Williamson
PARASITE IMMUNOLOGY (2003)
IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains
MP Lefranc et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2003)
P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions
AM Tomas et al.
EMBO JOURNAL (2001)
Current developments in malaria transmission-blocking vaccines
A Stowers et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum
WFG Roeffen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Plasmodium falciparum: Production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen
W Roeffen et al.
EXPERIMENTAL PARASITOLOGY (2001)
A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies
AW Stowers et al.
INFECTION AND IMMUNITY (2000)
Proteolysis of Plasmodium falciparum surface antigen, Pfs230, during gametogenesis
SR Brooks et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
分享论文
